FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmacology, namely to application of 9-(2-diethylaminoethyl)-2-(3,4-dioxyphenyl)imidaso[1,2-a]benzimidazole dihydrobromide of formula 
as compound, demonstrating higher antithrombogenic activity.
EFFECT: obtaining compound, demonstrating higher antithrombogenic activity.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
| ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
| DRUG POSSESSING ANTIHYPOXIC, ACTOPROTECTIVE, NOOTROPIC ACTIVITIES AND HAVING EFFECT ON PHYSICAL EFFICIENCY, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2462245C1 |
| 1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
| DIPOTASSIUM SALT OF N-(4-HYDROXYBENZOYL) TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2019 |
|
RU2731106C1 |
| HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
